Kuros Biosciences (CSBTF) Q4 2022 Earnings Report
CSBTF Q4 2022 EPS Results
- Actual EPS
- -$0.38
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -$0.27
CSBTF Q4 2022 Revenue Results
- Actual Revenue
- $9.14M
- Expected Revenue
- $9.63M
- Beat/Miss
- Missed by -$496.44K
- YoY Revenue Growth
- +59.86%
Earnings Announcement Details
- Quarter
- Q4 2022
- Date
- 03/15/2023
- Time
- Before Open
- Conference Call
- Wednesday, March 15, 2023
CSBTF Upcoming Earnings
Kuros Biosciences's next earnings date is estimated for March 3, 2027, based on past reporting schedules.
Q4 2022 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q4 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
CSBTF Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 03, 2027 | 2026 (Q4) | 0.10- | 0.11 | ― | ― |
| Aug 13, 2026 | 2026 (Q2) | 0.070.07 | -0.04 | 262.22% (+0.12) | |
| Mar 10, 2026 | 2025 (Q4) | 0.000.11 | -0.13 | 184.55% (+0.25) | |
| Aug 14, 2025 | 2025 (Q2) | ―-0.05 | -0.01 | -650.00% (-0.05) | |
| Mar 11, 2025 | 2024 (Q4) | ―-0.13 | -0.29 | 53.59% (+0.15) | |
| Aug 08, 2024 | 2024 (Q2) | ―-0.01 | -0.17 | 95.65% (+0.16) | |
| Mar 13, 2024 | 2023 (Q4) | ―-0.29 | -0.38 | 25.47% (+0.10) | |
| Aug 09, 2023 | 2023 (Q2) | ―-0.17 | -0.14 | -22.12% (-0.03) | |
| Mar 15, 2023 | 2022 (Q4) | ―-0.38 | -0.27 | -40.09% (-0.11) | |
| Aug 09, 2022 | 2022 (Q2) | ―-0.14 | 0 | -3666.67% (-0.13) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
